157 related articles for article (PubMed ID: 36388033)
21. LCMT1 indicates poor prognosis and is essential for cell proliferation in hepatocellular carcinoma.
Zhang N; Lu C; Mo J; Wang X; Liao S; Liang N; Feng M; Tang T; Wu Y; Li Y; Lan C; Chen C; Shi Q; Wei L; Zheng Z; Lei Y; Zhang Z; Tang S; Li X
Transl Oncol; 2023 Jan; 27():101572. PubMed ID: 36401967
[TBL] [Abstract][Full Text] [Related]
22. Fbxw7 regulates hepatocellular carcinoma migration and invasion via Notch1 signaling pathway.
Wang X; Zhang J; Zhou L; Sun W; Zheng ZG; Lu P; Gao Y; Yang XS; Zhang ZC; Tao KS; Dou KF
Int J Oncol; 2015 Jul; 47(1):231-43. PubMed ID: 25955618
[TBL] [Abstract][Full Text] [Related]
23. A Preliminary Investigation of PVT1 on the Effect and Mechanisms of Hepatocellular Carcinoma: Evidence from Clinical Data, a Meta-Analysis of 840 Cases, and In Vivo Validation.
Zhang Y; Wen DY; Zhang R; Huang JC; Lin P; Ren FH; Wang X; He Y; Yang H; Chen G; Luo DZ
Cell Physiol Biochem; 2018; 47(6):2216-2232. PubMed ID: 29975928
[TBL] [Abstract][Full Text] [Related]
24. Suppression of FAM83D Inhibits Glioma Proliferation, Invasion and Migration by Regulating the AKT/mTOR Signaling Pathway.
Li X; Sun C; Chen J; Ma JF; Pan YH
Transl Oncol; 2022 Aug; 22():101454. PubMed ID: 35617811
[TBL] [Abstract][Full Text] [Related]
25. BUB1B promotes hepatocellular carcinoma progression via activation of the mTORC1 signaling pathway.
Qiu J; Zhang S; Wang P; Wang H; Sha B; Peng H; Ju Z; Rao J; Lu L
Cancer Med; 2020 Nov; 9(21):8159-8172. PubMed ID: 32977361
[TBL] [Abstract][Full Text] [Related]
26. miRNA-495 suppresses proliferation and migration of colorectal cancer cells by targeting FAM83D.
Yan L; Yao J; Qiu J
Biomed Pharmacother; 2017 Dec; 96():974-981. PubMed ID: 29221726
[TBL] [Abstract][Full Text] [Related]
27. Knockdown of AKR1C3 Promoted Sorafenib Sensitivity Through Inhibiting the Phosphorylation of AKT in Hepatocellular Carcinoma.
Zheng J; Yang Z; Li Y; Yang L; Yao R
Front Oncol; 2022; 12():823491. PubMed ID: 35359392
[TBL] [Abstract][Full Text] [Related]
28. Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis.
Wang Y; Liu Z; Yao B; Li Q; Wang L; Wang C; Dou C; Xu M; Liu Q; Tu K
Mol Cancer; 2017 Jul; 16(1):123. PubMed ID: 28716020
[TBL] [Abstract][Full Text] [Related]
29. A liver-specific lncRNA, FAM99B, suppresses hepatocellular carcinoma progression through inhibition of cell proliferation, migration, and invasion.
Mo M; Liu S; Ma X; Tan C; Wei L; Sheng Y; Song Y; Zeng X; Huang D; Qiu X
J Cancer Res Clin Oncol; 2019 Aug; 145(8):2027-2038. PubMed ID: 31243545
[TBL] [Abstract][Full Text] [Related]
30. Knockdown of miR-106a suppresses migration and invasion and enhances radiosensitivity of hepatocellular carcinoma cells by upregulating FBXW7.
Deng P; Wu Y
Int J Clin Exp Pathol; 2019; 12(4):1184-1193. PubMed ID: 31933933
[TBL] [Abstract][Full Text] [Related]
31. SMG9 Serves as an Oncogene to Promote the Tumor Progression
Jin X; Yin J; Zhu H; Li W; Yu K; Liu M; Zhang X; Lu M; Wan Z; Huang X
Front Pharmacol; 2021; 12():701454. PubMed ID: 34456727
[No Abstract] [Full Text] [Related]
32. MicroRNA-25 Exerts an Oncogenic Function by Regulating the Ubiquitin Ligase Fbxw7 in Hepatocellular Carcinoma.
El-Mezayen H; Yamamura K; Yusa T; Nakao Y; Uemura N; Kitamura F; Itoyama R; Yamao T; Higashi T; Hayashi H; Imai K; Chikamoto A; Yamashita YI; Baba H
Ann Surg Oncol; 2021 Nov; 28(12):7973-7982. PubMed ID: 33886022
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of transcription factor 3 drives hepatocarcinoma development by enhancing cell proliferation via activating Wnt signaling pathway.
Pu XY; Zheng DF; Lv T; Zhou YJ; Yang JY; Jiang L
Hepatobiliary Pancreat Dis Int; 2022 Aug; 21(4):378-386. PubMed ID: 35033448
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma.
Li C; Wu M; Zong G; Wan C; Liu Q; Zhou H; Hua L; Chen Y; Chen X; Lu C
Dig Dis Sci; 2017 Jan; 62(1):133-142. PubMed ID: 27921263
[TBL] [Abstract][Full Text] [Related]
35. Upregulated mH2A1 serves as an unfavorable prognostic indicator and promotes the progress of hepatocellular carcinoma (HCC).
Yang G; Yao Y; Wu D; Guo H; Zhou S; Sun D; Guo X; Zheng T; Wang J; Zhang S; Wang Y; Song R; Ke S; Liu Y; Meng F; Liang Y; Lu Z; Liu L
Life Sci; 2020 Dec; 263():118576. PubMed ID: 33058912
[TBL] [Abstract][Full Text] [Related]
36. Upregulated LINC01667 Expression Is Correlated With Poor Prognosis in Hepatocellular Carcinoma.
Zhang K; Liu H; Yu M; Zhao H; Yang N; Bi X; Sun L; Lin R; Lü G
Front Oncol; 2021; 11():650173. PubMed ID: 34458133
[TBL] [Abstract][Full Text] [Related]
37. Alternatively activated NUSAP1 promotes tumor growth and indicates poor prognosis in hepatocellular carcinoma.
Shi C; Xu H; Liu J; Zhong Y; Zhang X; Tong X; Zhang L; Li X; Deng L
Transl Cancer Res; 2019 Feb; 8(1):238-247. PubMed ID: 35116752
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-27b exerts an oncogenic function by targeting Fbxw7 in human hepatocellular carcinoma.
Sun XF; Sun JP; Hou HT; Li K; Liu X; Ge QX
Tumour Biol; 2016 Nov; 37(11):15325-15332. PubMed ID: 27704356
[TBL] [Abstract][Full Text] [Related]
39. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
[TBL] [Abstract][Full Text] [Related]
40. The tumor suppressive miR-26a regulation of FBXO11 inhibits proliferation, migration and invasion of hepatocellular carcinoma cells.
Ma Y; Deng F; Li P; Chen G; Tao Y; Wang H
Biomed Pharmacother; 2018 May; 101():648-655. PubMed ID: 29518611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
